Perfil metabolómico diferencial en suero de pacientes con Esclerosis Sistémica y Síndrome de Sjögren

Las enfermedades autoinmunes son patologías que representan un problema de salud pública por el deterioro de la calidad de vida de las personas que las padecen. Estas enfermedades se definen como la respuesta anormal del sistema inmunológico a moléculas propias o autoantígenos específicos llevando a...

Full description

Autores:
Moreno Rubiano, Laura Alejandra
Sierra Hernández, Olga Lucía
Tipo de recurso:
Trabajo de grado de pregrado
Fecha de publicación:
2022
Institución:
Colegio Mayor de Cundinamarca
Repositorio:
Repositorio Colegio Mayor de Cundinamarca
Idioma:
spa
OAI Identifier:
oai:repositorio.unicolmayor.edu.co:unicolmayor/5673
Acceso en línea:
https://repositorio.unicolmayor.edu.co/handle/unicolmayor/5673
Palabra clave:
Suero
Metabolito
Ecología autoinmune
Autoinmunidad
Metabolómica
Esclerosis Sistémica
Síndrome de Sjögren
Rights
closedAccess
License
Derechos Reservados - Universidad Colegio Mayor de Cundinamarca, 2022
id UCOLMAYOR2_f3d10fafdcd5f3f3251c63691287a8d8
oai_identifier_str oai:repositorio.unicolmayor.edu.co:unicolmayor/5673
network_acronym_str UCOLMAYOR2
network_name_str Repositorio Colegio Mayor de Cundinamarca
repository_id_str
dc.title.eng.fl_str_mv Perfil metabolómico diferencial en suero de pacientes con Esclerosis Sistémica y Síndrome de Sjögren
title Perfil metabolómico diferencial en suero de pacientes con Esclerosis Sistémica y Síndrome de Sjögren
spellingShingle Perfil metabolómico diferencial en suero de pacientes con Esclerosis Sistémica y Síndrome de Sjögren
Suero
Metabolito
Ecología autoinmune
Autoinmunidad
Metabolómica
Esclerosis Sistémica
Síndrome de Sjögren
title_short Perfil metabolómico diferencial en suero de pacientes con Esclerosis Sistémica y Síndrome de Sjögren
title_full Perfil metabolómico diferencial en suero de pacientes con Esclerosis Sistémica y Síndrome de Sjögren
title_fullStr Perfil metabolómico diferencial en suero de pacientes con Esclerosis Sistémica y Síndrome de Sjögren
title_full_unstemmed Perfil metabolómico diferencial en suero de pacientes con Esclerosis Sistémica y Síndrome de Sjögren
title_sort Perfil metabolómico diferencial en suero de pacientes con Esclerosis Sistémica y Síndrome de Sjögren
dc.creator.fl_str_mv Moreno Rubiano, Laura Alejandra
Sierra Hernández, Olga Lucía
dc.contributor.advisor.none.fl_str_mv Acosta Ampudia, Yeny
Navarrete Ospina, Jeannette
dc.contributor.author.none.fl_str_mv Moreno Rubiano, Laura Alejandra
Sierra Hernández, Olga Lucía
dc.subject.lemb.none.fl_str_mv Suero
Metabolito
Ecología autoinmune
Autoinmunidad
topic Suero
Metabolito
Ecología autoinmune
Autoinmunidad
Metabolómica
Esclerosis Sistémica
Síndrome de Sjögren
dc.subject.proposal.spa.fl_str_mv Metabolómica
Esclerosis Sistémica
Síndrome de Sjögren
description Las enfermedades autoinmunes son patologías que representan un problema de salud pública por el deterioro de la calidad de vida de las personas que las padecen. Estas enfermedades se definen como la respuesta anormal del sistema inmunológico a moléculas propias o autoantígenos específicos llevando a daño en tejidos; su desarrollo es multifactorial, por lo que en su estudio es imprescindible tener en cuenta los factores ambientales, genéticos, entre otros. La metabolómica es la ciencia ómica que estudia metabolitos, por medio de esta se pueden estudiar eventos biológicos y así determinar alteraciones relevantes en procesos de enfermedades. Es así que el objetivo de esta investigación es abordar desde la perspectiva de la metabolómica los cambios que se pueden encontrar en perfiles metabolómicos entre pacientes con Esclerosis Sistémica y Síndrome de Sjögren. De esta forma se encuentra que hay metabolitos a destacar en estas enfermedades como los ácidos grasos y metabolitos derivados de aminoácidos entre ellos el triptófano los cuales pueden intervenir en su patología. Este estudio proporciona información relevante para futuras investigaciones, lo que supondría un apoyo en la búsqueda futura de nuevos metabolitos que puedan contribuir en el desarrollo de las enfermedades tratadas en este trabajo
publishDate 2022
dc.date.accessioned.none.fl_str_mv 2022-09-27T19:58:37Z
dc.date.available.none.fl_str_mv 2022-09-27T19:58:37Z
dc.date.issued.none.fl_str_mv 2022
dc.type.spa.fl_str_mv Trabajo de grado - Pregrado
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_7a1f
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.content.spa.fl_str_mv Text
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/bachelorThesis
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/TP
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
format http://purl.org/coar/resource_type/c_7a1f
status_str publishedVersion
dc.identifier.uri.none.fl_str_mv https://repositorio.unicolmayor.edu.co/handle/unicolmayor/5673
url https://repositorio.unicolmayor.edu.co/handle/unicolmayor/5673
dc.language.iso.spa.fl_str_mv spa
language spa
dc.relation.references.spa.fl_str_mv Inforeuma. Esclerosis Sistémica: Qué es, Síntomas, diagnóstico y tratamiento. [Internet]. [Citado 2021 Ago 14]. Disponible en: https://inforeuma.com/enfermedades-reumaticas/esclerosis-sistemica/
Clínic Barcelona. Síndrome de Sjögren. [Internet]. [Citado 2021 Ago 16]. Disponible en: https://www.clinicbarcelona.org/asistencia/enfermedades/sindrome-de-sjogren /evolucion-de-la-enfermedad
Anaya J, Santana C, Alzate M, González N, Villarraga A. The Autoimmune Ecology. Microbial Immunology. [Internet]. 2016; 26. [Cited 2022 mar 26]. Available in: https://www.frontiersin.org/articles/10.3389/fimmu.2016.00139/full
Anaya J, Jiménez P, Ramírez C. The autoimmune ecology: an update. Curr Opin Rheumatol. [Internet]. 2018 Jul;30(4):350-360. [Cited 2022 mar 26]. Available in: https://pubmed.ncbi.nlm.nih.gov/29438164/
Zhang Q, Yin X, Wang H, Wu X, Li X, Li Y, et al. Fecal Metabolomics and Potential Biomarkers for Systemic Lupus Erythematosus. Inmunol Frontal. [Internet] 2019; 10:976. [Cited 2022 mar 19]. Available in: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509220/
Mendoza C, Garcia M, Mendez S, Munguia P, Etchegaray I, Diaz G, et al. Metabolomic profile of insulin resistance in non-diabetic women with systemic lupus erythematosus. Scielo. [Internet]. 2021; 157. [Cited 2022 mar 26]. Available in: http://www.scielo.org.mx/scielo.php?pid=S0016-38132021000600613&script= sci_arttext)
Kalantari S, Chashmniam S, Nafar M, Zakeri Z, Parvin M. Metabolomics approach reveals urine biomarkers and pathways associated with the pathogenesis of lupus nephritis. Metabolomics approach reveals urine biomarkers and pathways associated with the pathogenesis of lupus nephritis. Iran J Basic Med Sci. [Internet]. 2019; 22(11):1288-1295. [Cited 2021 jun 13]. Available in: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038420/
Li J, Xie X-W, Zhou H, Wang B, Zhang M-J, Tang F-Y. Metabolic profiling reveals new serum biomarkers of lupus nephritis. Lupus. [Internet]. 2017;26(11):1166-1173. [Cited 2022 feb 10]. Available in: https://journals.sagepub.com/doi/10.1177/0961203317694256?url_ver=Z39.8 8-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed)
Zhang Q, Li X, Yin X, Wang H, Fu C, Wang H, et al. Metabolomic profiling reveals serum L-pyroglutamic acid as a potential diagnostic biomarker for systemic lupus erythematosus. Rheumatology. [Internet] Volume 60, Issue 2. 2021. [Cited 2022 mar 20]. Available in: https://doi.org/10.1093/rheumatology/keaa126
Anaya J, Shoenfeld Y, Correa PA, Carrasco MG, Cervera R. Autoinmunidad y Enfermedad Autoinmune. [Internet]. 1ra. ed. Colombia. CORPORACIÓN PARA INVESTIGACIONES BIOLÓGICAS. 2005. [Cited 2021 ene 15] Disponible en: https://repository.urosario.edu.co/handle/10336/28852?show=full
Theofilopoulos A N, Kono D H, Baccala R. The multiple pathways to autoimmunity. Nat Immunol. [Internet]. 2017 Jun 20;18(7):716-724. [Cited 2021 jun 17]. Available in: https://www.nature.com/articles/ni.3731
Holick F. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. AM J CLIN NUTR. [Internet]. 2004; 17. [Cited 2020 Oct 13]. Available in: 10.1093/ajcn/80.6.1678S
Herrmann I, Kellert M, Schmidt H, Mildner A, Hanish U, Bruck W, et al. Streptococcus pneumoniae Infection Aggravates Experimental Autoimmune Encephalomyelitis via Toll-Like Receptor 2. Infect Immun. [Internet]. 2006; 74:4841–4848. [Cited 2020 oct 13]. Available in: https://journals.asm.org/doi/10.1128/IAI.00026-06
Segerstrom S. Stress, Energy, and Immunity: An Ecological View. Curr Dir Psychol Sci. [Internet]. 2007; 16:326–330. [Cited 2020 Oct 13]. Available in: https://journals.sagepub.com/doi/abs/10.1111/j.1467-8721.2007.00522.x
Corsini E, Liesivuori J, Vergieva T, Van Loveren H, Colosio C. Effects of pesticide exposure on the human immune system. Hum Exp Toxicol. [Internet]. 2008; 27: 5846–5861. [Cited 2020 Oct 13]. Available in: https://www.mdpi.com/1660-4601/12/6/5846
Lebba V, Nicoletti M, Schippa S. Gut microbiota and the immune system: an intimate partnership in health and disease. INT J IMMUNOPATH PH. [Internet]. 2012; 25:823-833. [Cited 2020 Oct 13]. Available in: https://journals.sagepub.com/doi/10.1177/039463201202500401
Clark P M, Dawany N, Dampier W, Byers S W, Pestell R G, Tozeren A. Bioinformatic analysis reveals microRNA and transcriptome signatures and drug repositioning targets for IBD and other autoimmune diseases. Inflamm Bowel Dis. [Internet]. 2012; 18:2315-33. [Cited 2020 Oct 13]. Available in: 10.1002/ibd.22958
Karlén J, Faresjo T, Ludvigsson J. Could the social environment trigger the induction of diabetes related autoantibodies in young children? Scand. J. Public Health. [Internet]. 2012; 40(2):177-182. [Cited 2020 Oct 13]. Available in: https://doi.org/10.1177/1403494811435491
Guivier E, Galán M, Henttonen H, Cosson J, Charbonnel N. Landscape characteristics and helminth co-infection shape the immune heterogeneity of field mice, with consequences for the epidemiology of the Puumala virus. J. Heredity. [Internet]. 2013; 112: 274–281 [Cited 2020 Oct 13]. Available in: 10.1038/hdy.2013.103
Villarraga A, Hoz J, Fernández O, Amaya J, Franco J. Autoimmune ecology. 1 ed. [Internet]. Bogotá: Prensa Universitaria El Rosario. 2013 [Cited 2020 Oct 13]. Available in: https://editorial.urosario.edu.co/gpd-autoimmunity.html
Tiniakou E, Costenbader K, Kriegel M. Sex-specific environmental influences on the development of autoimmune diseases. J. Clin. Immunol. [Internet]. 2013; 149: 182-191 [Cited 2020 Oct 13]. Available in: https://www.sciencedirect.com/science/article/abs/pii/S1521661613000466
Brinkworth J, Barreiro L. The contribution of natural selection to present-day susceptibility to chronic inflammatory and autoimmune disease.Curr. Opin. Immunol. [Internet]. 2014; 31: 66–78 [Cited 2020 Oct 13]. Available in: https://pubmed.ncbi.nlm.nih.gov/25458997/
Franco JS, Anaya JM. The autoimmune tautology with a focus on antiphospholipid syndrome. Lupus. [Internet]. 2014; 23: 1273 - 1275 [Cited 2020 Oct 13]. Available in: https://journals.sagepub.com/doi/10.1177/0961203314537362
Wekerle H. The gut-brain connection: triggering of brain autoimmune diseases by commensal gut bacteria. J. Rheumatol. [Internet]. 2016; 55: 68 –75 [Cited 2020 Oct 13]. Available in: https://doi.org/10.1093/rheumatology/kew353
Huffnagle G, Dickson R, Lukacs N. The respiratory tract microbiome and lung inflammation: a two-way street, mucosal immunology. Mucosal Immunol. [Internet]. 2016; 10: 299 - 306 [Cited 2020 Oct 13]. Available in: https://doi.org/10.1038/mi.2016.108
García M, Jiménez E, Gálves J, Vázquez L, Mendoza C, Etchegaray I, et al. Vitamin D and Sjögren syndrome. [Internet]. 2017; 587-593. [Cited 2020 Nov 21]. Available in: https://doi.org/10.1016/j.autrev.2017.04.004
Lee C, Hsu P, Su C. Increased prevalence of Sjogren's syndrome in where soils contain high levels of chromium. [Internet]. 2019. 1121-1126. [Cited 2020 Nov 21]. Available in: https://doi.org/10.1016/j.scitotenv.2018.12.122
Cui L, Lu H, Lee YH. Challenges and emergent solutions for LC-MS/MS based untargeted metabolomics in diseases. Wiley Periodicals. [Internet]. 2018. [Cited 11 Mar 2021]. Available in: 10.1002/mas.21562
Gautier JC. Drug Safety Evaluation: Methods and Protocols. Humana Press. [Internet]. 2017. [Cited 11 Mar 2021]. Available in: https://link.springer.com/book/10.1007/978-1-60761-849-2
Sugimoto M, Kawakami M, Robert M, Soga T, Tomita M. Bioinformatics Tools for Mass Spectroscopy-Based Metabolomic Data Processing and Analysis. Current Bioinformatics. [Internet]. 2012; 7, 96-108. [Cited 11 Mar 2021]. Available in: https://pubmed.ncbi.nlm.nih.gov/22438836/
Cansın Ö, Eylem C, Reçber T, Kır S, Nemutlu E.Integration of GC–MS and LC–MS for untargeted metabolomics profiling. [Internet]. 2020; 190; 113509. [Cited 2021 Abr 16]. Available in: https://doi.org/10.1016/j.jpba.2020.113509
Ribbenstedt A, Ziarrusta H, Benskin JP. Development, characterization and comparisons of targeted and non-targeted metabolomics methods. PLoS ONE. [Internet]. 2018; 13(11). [Cited 11 Mar 2021]. Available in: https://doi.org/10.1371/journal.pone.0207082
Barnes S, Benton H, Casazza K, Cooper S, Cui X, Du X, et al. Training in metabolomics research. II. Processing and statistical analysis of metabolomics data, metabolite identification, pathway analysis, applications of metabolomics and its future. J Mass Spectrom. [Internet]. 2016 Aug; 51(8): 535–548. [Cited 2021 Abr 15]. Available in: https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/jms.3 780
MZmine. MZmine 3. [Internet]. 2015. [Cited 2021 Abr 15]. Available in: http://mzmine.github.io
Wold S, Sjöström M, Eriksson L. PLS-regression: a basic tool of chemometrics. Chemometr Intell Lab Syst. [Internet]. 2001; 58(2): 109-130. [Cited 2021 Abr 15]. Available in: https://doi.org/10.1016/S0169-7439(01)00155-1
Zubiri A. Análisis metabolómico no dirigido en dos líneas de conejos seleccionadas de forma divergente para grasa intramuscular. [Internet]. 2018. [Citado el 2021 Abr 17]. Disponible en: https://riunet.upv.es/bitstream/handle/10251/112032/Zubiri%20-%20An%C3% A1lisis%20metabol%C3%B3mico%20no
Iriondo G. Estudio metabolómico de los efectos relacionados con la escasez de agua durante el crecimiento de los cultivos de arroz (Oryza sativa japonica). [Internet]. 2016. [Citado el 2021 Abr 17]. Disponible en: https://upcommons.upc.edu/bitstream/handle/2117/106001/TFM_GUILLERM O_IRIONDO.pdf?sequence=1&isAllowed=y
Garcia N, Rubio R, Emperiale V, Movasat A, Systemic sclerosis. [Internet]. 2021; 1769-1778. [Cited 18 Ago 2021]. Available in: https://doi.org/10.1016/j.med.2021.04.004
Herrera M, Monge P, ESCLEROSIS SISTÉMICA CUTÁNEA, [Internet]. 2015; 591 - 596. [Cited 18 Ago 2021]. Available in: https://www.medigraphic.com/pdfs/revmedcoscen/rmc-2015/rmc153o.pdf
MiSistemaInmune. ESCLERODERMIA Y SISTEMA INMUNE. [Internet]. 2017. [Citado 2021 Ago 14]. Disponible en: https://www.misistemainmune.es/enfermedades-sistema-inmunitario/autoinmu nes/esclerodermia-y-sistema-inmune
Medline Plus. Síndrome de Sjögren. [Internet]. 2020. [Citado 2021 Abr 27]. Disponible en: https://medlineplus.gov/spanish/sjogrenssyndrome.html
Bjordal O, Norheim K, Rødahl E, Jonsson R, Omdal R. Primary Sjögren’s syndrome and the eye. Surv. Ophthalmol. [Internet] 2020. [Cited 2021 Ago 11] DOI: https://www.sciencedirect.com/science/article/pii/S0039625719302838
Mavragani C, Haralampos M. Sjögren's syndrome: Old and new therapeutic targets. J. Autoimmunity. [Internet]. 2020; 110, 102364. [Cited 2021 Abr 15]. Available in: https://doi.org/10.1016/j.jaut.2019.102364
Soyfoo M S, Nicaise C. Pathophysiologic role of Interleukin-33/ST2 in Sjögren's syndrome. Autoimmun. Rev. [Internet]. 2021; 20 (3): 102756. [Cited 2021 Ago 11]. Available in: https://www.sciencedirect.com/science/article/abs/pii/S156899722100015X
Psianou K, Panagoulias I, Papanastasiou A D, de Lastic A, Spantidea P I, Degn S E, et al. Clinical and immunological parameters of Sjögren's syndrome. Autoimmun. Rev. [Internet]. 2018; 17 (10): 1053-1064. [Cited 2021 Ago 11]. Available in: 10.1016/J.AUTREV.2018.05.005
Bengtsson AA, Trygg J, Wuttge DM, Sturfelt G, Theander E, Donten M, et al. Metabolic Profiling of Systemic Lupus Erythematosus and Comparison with Primary Sjögren’s Syndrome and Systemic Sclerosis. [Internet]. PLoS ONE 11(7): e0159384. [Cited 2022 mar 20] Available in: 10.1371/journal.pone.0159384
Xu T, Guo Y, Lu J, Shan J, Lin L, Qian W, et al. Untargeted serum metabolomics and potential biomarkers for Sjögren’s syndrome. Clin Exp Rheumatol. [Internet]. 2021. [Cited 19 mar 2022]. Available in: PMID: 34251320.
Fernández Á, Borrás I, Quirantes R, Alarcón M, Beretta L, Segura A; Precisesads Clinical Consortium. Discovering new metabolite alterations in primary sjögren's syndrome in urinary and plasma samples using an HPLC-ESI-QTOF-MS methodology. J Pharm Biomed Anal. [Internet]. 2020. Feb 5;179:112999. [Cited 20 mar 2022] Available in: 10.1016/j.jpba.2019.112999.
Maria NI, van Helden-Meeuwsen CG, Brkic Z, Paulissen SM, Steenwijk EC, Dalm VA, et al. Association of Increased Treg Cell Levels With Elevated Indoleamine 2,3-Dioxygenase Activity and an Imbalanced Kynurenine Pathway in Interferon-Positive Primary Sjögren's Syndrome. Arthritis Rheumatol. [Internet]. 2016 Jul;68(7):1688-99. [Cited 20 mar 2022] Available in: 10.1002/art.39629
Gold R, Kappos L, Arnold D, Bar-Or A, Giovannoni G, Selmaj K, et al. Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis. N Engl J Med [Internet]. 2012. 2012;367:1098-107. [Cited 2021 Abr 11]. Available in: 10.1056/NEJMoa1114287
Smolenska Z, Kaczorowska M, Wojteczek A, Zajac B, Zdrojewski Z. Metabolic pattern of systemic sclerosis: association of changes in plasma concentrations of amino acid-related compounds with the presentation of the disease. NLM. [Internet]. 2020;7:585161. [Cited 2021 Abr 17] Available in: doi:10.3389/fmolb.2020.58516
Murgia F, Svegliati S, Poddighe S, Lussu M, Manzin A, Spadoni T, et al. Metabolomic profile of systemic sclerosis patients. Sci. Rep. [Internet]. 2018; 8, 7626. [Cited 2021 Abr 17]. Available in: https://doi.org/10.1038/s41598-018-25992-7
Mok M, Fung P, Ooi C, Tse H, Wong Y, Lam Y, et al. Serum nitric oxide metabolites and disease activity in patients with systemic sclerosis. Clin Rheumatol. [Internet]. 2007.27, 315–322. [Cited 2021 Abr 16] Available in: 10.1007/s10067-007-0708-9
Meier C, Freiburghaus K, Bovet C, Schniering J, Allanore Y, Distler O, el al. biomarkers in systemic sclerosis-associated interstitial lung disease. Scientific Reports. [Internet]. 2020. [Cited 2021 Abr 16] Available in: https://doi.org/10.1038/s41598-020-78951-6
Reis F, Fantucci M, Adriano L, Valim V, Mattar T, Louzada-Junior P, et al. Neurological and Inflammatory Manifestations in Sjögren’s Syndrome: The Role of the Kynurenine Metabolic Pathway. Int J Mol Sci. [Internet]. 2018 Dec; 19(12): 3953. [Cited 2021 Abr 15]. Available in: 10.3390/ijms19123953
Fernández A, Borrás I, Quirantes R, Alarcón M, Beretta L, Segura A, et al. Discovering new metabolite alterations in primary sjögren’s syndrome in urinary and plasma samples using an HPLC-ESI-QTOF-MS methodology. J. Pharm. [Internet]. 2020; 179(5): 112999. [Cited 2021 Abr 15]. Available in: https://doi.org/10.1016/j.jpba.2019.112999
Kageyama G, Saegusa J,Irino Y, Tanaka S, Tsuda K, Takahashi S, et al. Metabolomics analysis of saliva from patients with primary Sjögren's syndrome. Clin Exp Immunol. [Internet]. 2015 Nov; 182(2): 149–153. [Cited 2021 Abr 15]. Available in: 10.1111/cei.12683
dc.rights.spa.fl_str_mv Derechos Reservados - Universidad Colegio Mayor de Cundinamarca, 2022
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/closedAccess
dc.rights.creativecommons.spa.fl_str_mv Atribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_14cb
rights_invalid_str_mv Derechos Reservados - Universidad Colegio Mayor de Cundinamarca, 2022
https://creativecommons.org/licenses/by-nc-sa/4.0/
Atribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)
http://purl.org/coar/access_right/c_14cb
eu_rights_str_mv closedAccess
dc.format.extent.spa.fl_str_mv 63p.
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.faculty.spa.fl_str_mv Facultad de Ciencias de la Salud
dc.publisher.place.spa.fl_str_mv Bogotá D.C
dc.publisher.program.spa.fl_str_mv Bacteriología y Laboratorio Clínico
institution Colegio Mayor de Cundinamarca
bitstream.url.fl_str_mv https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5673/2/license.txt
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5673/6/Perfil%20metabol%c3%b3mico%20diferencial%20en%20suero%20de%20pacientes%20con%20SSc%20y%20SSp.docx%20%281%29.pdf.txt
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5673/8/PERFIL%20METABOL%c3%93MICO%20DIFERENCIAL%20EN%20SUERO%20DE%20PACIENTES%20CON%20ESCLEROSIS%20SIST%c3%89MICA%20Y%20S%c3%8dNDROME%20DE%20SJ%c3%96GREN..pdf.txt
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5673/10/FORMATO%20IDENTIFICACI%c3%93N%20TRABAJOS%20DE%20GRADO%281%29%20%282%29.pdf.txt
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5673/12/CARTA%20DERECHOS%20DE%20AUTOR%20Moreno.pdf.txt
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5673/7/Perfil%20metabol%c3%b3mico%20diferencial%20en%20suero%20de%20pacientes%20con%20SSc%20y%20SSp.docx%20%281%29.pdf.jpg
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5673/9/PERFIL%20METABOL%c3%93MICO%20DIFERENCIAL%20EN%20SUERO%20DE%20PACIENTES%20CON%20ESCLEROSIS%20SIST%c3%89MICA%20Y%20S%c3%8dNDROME%20DE%20SJ%c3%96GREN..pdf.jpg
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5673/11/FORMATO%20IDENTIFICACI%c3%93N%20TRABAJOS%20DE%20GRADO%281%29%20%282%29.pdf.jpg
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5673/13/CARTA%20DERECHOS%20DE%20AUTOR%20Moreno.pdf.jpg
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5673/14/Perfil%20metabol%c3%b3mico%20diferencial%20en%20suero%20de%20pacientes%20con%20SSc%20y%20SSp.docx%20%281%29.pdf
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5673/15/PERFIL%20METABOL%c3%93MICO%20DIFERENCIAL%20EN%20SUERO%20DE%20PACIENTES%20CON%20ESCLEROSIS%20SIST%c3%89MICA%20Y%20S%c3%8dNDROME%20DE%20SJ%c3%96GREN..pdf
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5673/16/CARTA%20DERECHOS%20DE%20AUTOR%20Moreno.pdf
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5673/17/FORMATO%20IDENTIFICACI%c3%93N%20TRABAJOS%20DE%20GRADO%281%29%20%282%29.pdf
bitstream.checksum.fl_str_mv 2f9959eaf5b71fae44bbf9ec84150c7a
9507c027285d37edacb2395665180301
23eb9a9e3b039d9571b7e40efdc99eaa
e66171aa8e2e99a4d3a33072f08d1a84
6d061587f2c279b6f94756191bc20cb5
0e25e77e8c24627387e3d03fa74de085
049b90ce9d70e510632911381c7bd6a3
6476e48add1b4e6d9acf929809543079
5cc543b4af894390b2b8b93ff520d27e
10e5e8c13f80cb858e9d8fa98ac4a5b9
488182d58744cb369b3a4c44b2e90d57
193e8d468ee4fb04513ad9ac9a787806
a414708b05a59fec2dea9018356e2535
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
MD5
MD5
MD5
MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Biblioteca Digital Unicolmayor
repository.mail.fl_str_mv repositorio@unicolmayor.edu.co
_version_ 1812210015414517760
spelling Acosta Ampudia, Yenyb4f0c7e62e1aa24474436273a30dc094Navarrete Ospina, Jeannette2501b1f12f56f0da5153076c8e218e13600Moreno Rubiano, Laura Alejandrab11edb52b814b667cb729adc9af21499Sierra Hernández, Olga Lucíae876d85adf89a7fc3ae28052901adcc82022-09-27T19:58:37Z2022-09-27T19:58:37Z2022https://repositorio.unicolmayor.edu.co/handle/unicolmayor/5673Las enfermedades autoinmunes son patologías que representan un problema de salud pública por el deterioro de la calidad de vida de las personas que las padecen. Estas enfermedades se definen como la respuesta anormal del sistema inmunológico a moléculas propias o autoantígenos específicos llevando a daño en tejidos; su desarrollo es multifactorial, por lo que en su estudio es imprescindible tener en cuenta los factores ambientales, genéticos, entre otros. La metabolómica es la ciencia ómica que estudia metabolitos, por medio de esta se pueden estudiar eventos biológicos y así determinar alteraciones relevantes en procesos de enfermedades. Es así que el objetivo de esta investigación es abordar desde la perspectiva de la metabolómica los cambios que se pueden encontrar en perfiles metabolómicos entre pacientes con Esclerosis Sistémica y Síndrome de Sjögren. De esta forma se encuentra que hay metabolitos a destacar en estas enfermedades como los ácidos grasos y metabolitos derivados de aminoácidos entre ellos el triptófano los cuales pueden intervenir en su patología. Este estudio proporciona información relevante para futuras investigaciones, lo que supondría un apoyo en la búsqueda futura de nuevos metabolitos que puedan contribuir en el desarrollo de las enfermedades tratadas en este trabajoTabla de contenido Resumen 8 Introducción 9 1. Antecedentes 11 2. Marco Teórico 13 2.1 Autoinmunidad y ecología autoinmune 13 2.2 Metabolómica 18 2.2.1 Técnicas utilizadas en metabolómica 19 2.2.2 Análisis bioestadístico de datos 22 2.3 Esclerosis Sistémica y Síndrome de Sjogren 24 2.3.1 Esclerosis Sistémica 24 2.3.2 Síndrome de Sjogren 26 3. Diseño Metodológico 28 3.1. Universo, población, muestra 28 3.2. Hipótesis, variables, indicadores 28 3.3. Operacionalización de las variables 29 3.4. Técnicas y procedimientos 30 4. Resultados 31 4.1 Metabolitos encontrados en Esclerosis Sistémica y Síndrome de Sjogren 32 4.2 Rutas metabólicas alteradas en Esclerosis Sistémica y Síndrome de Sjogren 34 5. Discusión 38 5.1 Metabolómica de Esclerosis Sistémica 38 5.2 Metabolomica de Síndrome de Sjogren 40 5.3 Metabolómica de Esclerosis Sistémica y Síndrome de Sjogren 43 6. Conclusiones 43 7. Perspectivas 44 8. Referencias Bibliográficas 45 9. Anexos 54PregradoBacteriólogo(a) y Laboratorista Clínico63p.application/pdfspaDerechos Reservados - Universidad Colegio Mayor de Cundinamarca, 2022https://creativecommons.org/licenses/by-nc-sa/4.0/info:eu-repo/semantics/closedAccessAtribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)http://purl.org/coar/access_right/c_14cbPerfil metabolómico diferencial en suero de pacientes con Esclerosis Sistémica y Síndrome de SjögrenTrabajo de grado - Pregradohttp://purl.org/coar/resource_type/c_7a1fhttp://purl.org/coar/version/c_970fb48d4fbd8a85Textinfo:eu-repo/semantics/bachelorThesishttps://purl.org/redcol/resource_type/TPinfo:eu-repo/semantics/publishedVersionFacultad de Ciencias de la SaludBogotá D.CBacteriología y Laboratorio ClínicoInforeuma. Esclerosis Sistémica: Qué es, Síntomas, diagnóstico y tratamiento. [Internet]. [Citado 2021 Ago 14]. Disponible en: https://inforeuma.com/enfermedades-reumaticas/esclerosis-sistemica/Clínic Barcelona. Síndrome de Sjögren. [Internet]. [Citado 2021 Ago 16]. Disponible en: https://www.clinicbarcelona.org/asistencia/enfermedades/sindrome-de-sjogren /evolucion-de-la-enfermedadAnaya J, Santana C, Alzate M, González N, Villarraga A. The Autoimmune Ecology. Microbial Immunology. [Internet]. 2016; 26. [Cited 2022 mar 26]. Available in: https://www.frontiersin.org/articles/10.3389/fimmu.2016.00139/fullAnaya J, Jiménez P, Ramírez C. The autoimmune ecology: an update. Curr Opin Rheumatol. [Internet]. 2018 Jul;30(4):350-360. [Cited 2022 mar 26]. Available in: https://pubmed.ncbi.nlm.nih.gov/29438164/Zhang Q, Yin X, Wang H, Wu X, Li X, Li Y, et al. Fecal Metabolomics and Potential Biomarkers for Systemic Lupus Erythematosus. Inmunol Frontal. [Internet] 2019; 10:976. [Cited 2022 mar 19]. Available in: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509220/Mendoza C, Garcia M, Mendez S, Munguia P, Etchegaray I, Diaz G, et al. Metabolomic profile of insulin resistance in non-diabetic women with systemic lupus erythematosus. Scielo. [Internet]. 2021; 157. [Cited 2022 mar 26]. Available in: http://www.scielo.org.mx/scielo.php?pid=S0016-38132021000600613&script= sci_arttext)Kalantari S, Chashmniam S, Nafar M, Zakeri Z, Parvin M. Metabolomics approach reveals urine biomarkers and pathways associated with the pathogenesis of lupus nephritis. Metabolomics approach reveals urine biomarkers and pathways associated with the pathogenesis of lupus nephritis. Iran J Basic Med Sci. [Internet]. 2019; 22(11):1288-1295. [Cited 2021 jun 13]. Available in: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038420/Li J, Xie X-W, Zhou H, Wang B, Zhang M-J, Tang F-Y. Metabolic profiling reveals new serum biomarkers of lupus nephritis. Lupus. [Internet]. 2017;26(11):1166-1173. [Cited 2022 feb 10]. Available in: https://journals.sagepub.com/doi/10.1177/0961203317694256?url_ver=Z39.8 8-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed)Zhang Q, Li X, Yin X, Wang H, Fu C, Wang H, et al. Metabolomic profiling reveals serum L-pyroglutamic acid as a potential diagnostic biomarker for systemic lupus erythematosus. Rheumatology. [Internet] Volume 60, Issue 2. 2021. [Cited 2022 mar 20]. Available in: https://doi.org/10.1093/rheumatology/keaa126Anaya J, Shoenfeld Y, Correa PA, Carrasco MG, Cervera R. Autoinmunidad y Enfermedad Autoinmune. [Internet]. 1ra. ed. Colombia. CORPORACIÓN PARA INVESTIGACIONES BIOLÓGICAS. 2005. [Cited 2021 ene 15] Disponible en: https://repository.urosario.edu.co/handle/10336/28852?show=fullTheofilopoulos A N, Kono D H, Baccala R. The multiple pathways to autoimmunity. Nat Immunol. [Internet]. 2017 Jun 20;18(7):716-724. [Cited 2021 jun 17]. Available in: https://www.nature.com/articles/ni.3731Holick F. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. AM J CLIN NUTR. [Internet]. 2004; 17. [Cited 2020 Oct 13]. Available in: 10.1093/ajcn/80.6.1678SHerrmann I, Kellert M, Schmidt H, Mildner A, Hanish U, Bruck W, et al. Streptococcus pneumoniae Infection Aggravates Experimental Autoimmune Encephalomyelitis via Toll-Like Receptor 2. Infect Immun. [Internet]. 2006; 74:4841–4848. [Cited 2020 oct 13]. Available in: https://journals.asm.org/doi/10.1128/IAI.00026-06Segerstrom S. Stress, Energy, and Immunity: An Ecological View. Curr Dir Psychol Sci. [Internet]. 2007; 16:326–330. [Cited 2020 Oct 13]. Available in: https://journals.sagepub.com/doi/abs/10.1111/j.1467-8721.2007.00522.xCorsini E, Liesivuori J, Vergieva T, Van Loveren H, Colosio C. Effects of pesticide exposure on the human immune system. Hum Exp Toxicol. [Internet]. 2008; 27: 5846–5861. [Cited 2020 Oct 13]. Available in: https://www.mdpi.com/1660-4601/12/6/5846Lebba V, Nicoletti M, Schippa S. Gut microbiota and the immune system: an intimate partnership in health and disease. INT J IMMUNOPATH PH. [Internet]. 2012; 25:823-833. [Cited 2020 Oct 13]. Available in: https://journals.sagepub.com/doi/10.1177/039463201202500401Clark P M, Dawany N, Dampier W, Byers S W, Pestell R G, Tozeren A. Bioinformatic analysis reveals microRNA and transcriptome signatures and drug repositioning targets for IBD and other autoimmune diseases. Inflamm Bowel Dis. [Internet]. 2012; 18:2315-33. [Cited 2020 Oct 13]. Available in: 10.1002/ibd.22958Karlén J, Faresjo T, Ludvigsson J. Could the social environment trigger the induction of diabetes related autoantibodies in young children? Scand. J. Public Health. [Internet]. 2012; 40(2):177-182. [Cited 2020 Oct 13]. Available in: https://doi.org/10.1177/1403494811435491Guivier E, Galán M, Henttonen H, Cosson J, Charbonnel N. Landscape characteristics and helminth co-infection shape the immune heterogeneity of field mice, with consequences for the epidemiology of the Puumala virus. J. Heredity. [Internet]. 2013; 112: 274–281 [Cited 2020 Oct 13]. Available in: 10.1038/hdy.2013.103Villarraga A, Hoz J, Fernández O, Amaya J, Franco J. Autoimmune ecology. 1 ed. [Internet]. Bogotá: Prensa Universitaria El Rosario. 2013 [Cited 2020 Oct 13]. Available in: https://editorial.urosario.edu.co/gpd-autoimmunity.htmlTiniakou E, Costenbader K, Kriegel M. Sex-specific environmental influences on the development of autoimmune diseases. J. Clin. Immunol. [Internet]. 2013; 149: 182-191 [Cited 2020 Oct 13]. Available in: https://www.sciencedirect.com/science/article/abs/pii/S1521661613000466Brinkworth J, Barreiro L. The contribution of natural selection to present-day susceptibility to chronic inflammatory and autoimmune disease.Curr. Opin. Immunol. [Internet]. 2014; 31: 66–78 [Cited 2020 Oct 13]. Available in: https://pubmed.ncbi.nlm.nih.gov/25458997/Franco JS, Anaya JM. The autoimmune tautology with a focus on antiphospholipid syndrome. Lupus. [Internet]. 2014; 23: 1273 - 1275 [Cited 2020 Oct 13]. Available in: https://journals.sagepub.com/doi/10.1177/0961203314537362Wekerle H. The gut-brain connection: triggering of brain autoimmune diseases by commensal gut bacteria. J. Rheumatol. [Internet]. 2016; 55: 68 –75 [Cited 2020 Oct 13]. Available in: https://doi.org/10.1093/rheumatology/kew353Huffnagle G, Dickson R, Lukacs N. The respiratory tract microbiome and lung inflammation: a two-way street, mucosal immunology. Mucosal Immunol. [Internet]. 2016; 10: 299 - 306 [Cited 2020 Oct 13]. Available in: https://doi.org/10.1038/mi.2016.108García M, Jiménez E, Gálves J, Vázquez L, Mendoza C, Etchegaray I, et al. Vitamin D and Sjögren syndrome. [Internet]. 2017; 587-593. [Cited 2020 Nov 21]. Available in: https://doi.org/10.1016/j.autrev.2017.04.004Lee C, Hsu P, Su C. Increased prevalence of Sjogren's syndrome in where soils contain high levels of chromium. [Internet]. 2019. 1121-1126. [Cited 2020 Nov 21]. Available in: https://doi.org/10.1016/j.scitotenv.2018.12.122Cui L, Lu H, Lee YH. Challenges and emergent solutions for LC-MS/MS based untargeted metabolomics in diseases. Wiley Periodicals. [Internet]. 2018. [Cited 11 Mar 2021]. Available in: 10.1002/mas.21562Gautier JC. Drug Safety Evaluation: Methods and Protocols. Humana Press. [Internet]. 2017. [Cited 11 Mar 2021]. Available in: https://link.springer.com/book/10.1007/978-1-60761-849-2Sugimoto M, Kawakami M, Robert M, Soga T, Tomita M. Bioinformatics Tools for Mass Spectroscopy-Based Metabolomic Data Processing and Analysis. Current Bioinformatics. [Internet]. 2012; 7, 96-108. [Cited 11 Mar 2021]. Available in: https://pubmed.ncbi.nlm.nih.gov/22438836/Cansın Ö, Eylem C, Reçber T, Kır S, Nemutlu E.Integration of GC–MS and LC–MS for untargeted metabolomics profiling. [Internet]. 2020; 190; 113509. [Cited 2021 Abr 16]. Available in: https://doi.org/10.1016/j.jpba.2020.113509Ribbenstedt A, Ziarrusta H, Benskin JP. Development, characterization and comparisons of targeted and non-targeted metabolomics methods. PLoS ONE. [Internet]. 2018; 13(11). [Cited 11 Mar 2021]. Available in: https://doi.org/10.1371/journal.pone.0207082Barnes S, Benton H, Casazza K, Cooper S, Cui X, Du X, et al. Training in metabolomics research. II. Processing and statistical analysis of metabolomics data, metabolite identification, pathway analysis, applications of metabolomics and its future. J Mass Spectrom. [Internet]. 2016 Aug; 51(8): 535–548. [Cited 2021 Abr 15]. Available in: https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/jms.3 780MZmine. MZmine 3. [Internet]. 2015. [Cited 2021 Abr 15]. Available in: http://mzmine.github.ioWold S, Sjöström M, Eriksson L. PLS-regression: a basic tool of chemometrics. Chemometr Intell Lab Syst. [Internet]. 2001; 58(2): 109-130. [Cited 2021 Abr 15]. Available in: https://doi.org/10.1016/S0169-7439(01)00155-1Zubiri A. Análisis metabolómico no dirigido en dos líneas de conejos seleccionadas de forma divergente para grasa intramuscular. [Internet]. 2018. [Citado el 2021 Abr 17]. Disponible en: https://riunet.upv.es/bitstream/handle/10251/112032/Zubiri%20-%20An%C3% A1lisis%20metabol%C3%B3mico%20noIriondo G. Estudio metabolómico de los efectos relacionados con la escasez de agua durante el crecimiento de los cultivos de arroz (Oryza sativa japonica). [Internet]. 2016. [Citado el 2021 Abr 17]. Disponible en: https://upcommons.upc.edu/bitstream/handle/2117/106001/TFM_GUILLERM O_IRIONDO.pdf?sequence=1&isAllowed=yGarcia N, Rubio R, Emperiale V, Movasat A, Systemic sclerosis. [Internet]. 2021; 1769-1778. [Cited 18 Ago 2021]. Available in: https://doi.org/10.1016/j.med.2021.04.004Herrera M, Monge P, ESCLEROSIS SISTÉMICA CUTÁNEA, [Internet]. 2015; 591 - 596. [Cited 18 Ago 2021]. Available in: https://www.medigraphic.com/pdfs/revmedcoscen/rmc-2015/rmc153o.pdfMiSistemaInmune. ESCLERODERMIA Y SISTEMA INMUNE. [Internet]. 2017. [Citado 2021 Ago 14]. Disponible en: https://www.misistemainmune.es/enfermedades-sistema-inmunitario/autoinmu nes/esclerodermia-y-sistema-inmuneMedline Plus. Síndrome de Sjögren. [Internet]. 2020. [Citado 2021 Abr 27]. Disponible en: https://medlineplus.gov/spanish/sjogrenssyndrome.htmlBjordal O, Norheim K, Rødahl E, Jonsson R, Omdal R. Primary Sjögren’s syndrome and the eye. Surv. Ophthalmol. [Internet] 2020. [Cited 2021 Ago 11] DOI: https://www.sciencedirect.com/science/article/pii/S0039625719302838Mavragani C, Haralampos M. Sjögren's syndrome: Old and new therapeutic targets. J. Autoimmunity. [Internet]. 2020; 110, 102364. [Cited 2021 Abr 15]. Available in: https://doi.org/10.1016/j.jaut.2019.102364Soyfoo M S, Nicaise C. Pathophysiologic role of Interleukin-33/ST2 in Sjögren's syndrome. Autoimmun. Rev. [Internet]. 2021; 20 (3): 102756. [Cited 2021 Ago 11]. Available in: https://www.sciencedirect.com/science/article/abs/pii/S156899722100015XPsianou K, Panagoulias I, Papanastasiou A D, de Lastic A, Spantidea P I, Degn S E, et al. Clinical and immunological parameters of Sjögren's syndrome. Autoimmun. Rev. [Internet]. 2018; 17 (10): 1053-1064. [Cited 2021 Ago 11]. Available in: 10.1016/J.AUTREV.2018.05.005Bengtsson AA, Trygg J, Wuttge DM, Sturfelt G, Theander E, Donten M, et al. Metabolic Profiling of Systemic Lupus Erythematosus and Comparison with Primary Sjögren’s Syndrome and Systemic Sclerosis. [Internet]. PLoS ONE 11(7): e0159384. [Cited 2022 mar 20] Available in: 10.1371/journal.pone.0159384Xu T, Guo Y, Lu J, Shan J, Lin L, Qian W, et al. Untargeted serum metabolomics and potential biomarkers for Sjögren’s syndrome. Clin Exp Rheumatol. [Internet]. 2021. [Cited 19 mar 2022]. Available in: PMID: 34251320.Fernández Á, Borrás I, Quirantes R, Alarcón M, Beretta L, Segura A; Precisesads Clinical Consortium. Discovering new metabolite alterations in primary sjögren's syndrome in urinary and plasma samples using an HPLC-ESI-QTOF-MS methodology. J Pharm Biomed Anal. [Internet]. 2020. Feb 5;179:112999. [Cited 20 mar 2022] Available in: 10.1016/j.jpba.2019.112999.Maria NI, van Helden-Meeuwsen CG, Brkic Z, Paulissen SM, Steenwijk EC, Dalm VA, et al. Association of Increased Treg Cell Levels With Elevated Indoleamine 2,3-Dioxygenase Activity and an Imbalanced Kynurenine Pathway in Interferon-Positive Primary Sjögren's Syndrome. Arthritis Rheumatol. [Internet]. 2016 Jul;68(7):1688-99. [Cited 20 mar 2022] Available in: 10.1002/art.39629Gold R, Kappos L, Arnold D, Bar-Or A, Giovannoni G, Selmaj K, et al. Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis. N Engl J Med [Internet]. 2012. 2012;367:1098-107. [Cited 2021 Abr 11]. Available in: 10.1056/NEJMoa1114287Smolenska Z, Kaczorowska M, Wojteczek A, Zajac B, Zdrojewski Z. Metabolic pattern of systemic sclerosis: association of changes in plasma concentrations of amino acid-related compounds with the presentation of the disease. NLM. [Internet]. 2020;7:585161. [Cited 2021 Abr 17] Available in: doi:10.3389/fmolb.2020.58516Murgia F, Svegliati S, Poddighe S, Lussu M, Manzin A, Spadoni T, et al. Metabolomic profile of systemic sclerosis patients. Sci. Rep. [Internet]. 2018; 8, 7626. [Cited 2021 Abr 17]. Available in: https://doi.org/10.1038/s41598-018-25992-7Mok M, Fung P, Ooi C, Tse H, Wong Y, Lam Y, et al. Serum nitric oxide metabolites and disease activity in patients with systemic sclerosis. Clin Rheumatol. [Internet]. 2007.27, 315–322. [Cited 2021 Abr 16] Available in: 10.1007/s10067-007-0708-9Meier C, Freiburghaus K, Bovet C, Schniering J, Allanore Y, Distler O, el al. biomarkers in systemic sclerosis-associated interstitial lung disease. Scientific Reports. [Internet]. 2020. [Cited 2021 Abr 16] Available in: https://doi.org/10.1038/s41598-020-78951-6Reis F, Fantucci M, Adriano L, Valim V, Mattar T, Louzada-Junior P, et al. Neurological and Inflammatory Manifestations in Sjögren’s Syndrome: The Role of the Kynurenine Metabolic Pathway. Int J Mol Sci. [Internet]. 2018 Dec; 19(12): 3953. [Cited 2021 Abr 15]. Available in: 10.3390/ijms19123953Fernández A, Borrás I, Quirantes R, Alarcón M, Beretta L, Segura A, et al. Discovering new metabolite alterations in primary sjögren’s syndrome in urinary and plasma samples using an HPLC-ESI-QTOF-MS methodology. J. Pharm. [Internet]. 2020; 179(5): 112999. [Cited 2021 Abr 15]. Available in: https://doi.org/10.1016/j.jpba.2019.112999Kageyama G, Saegusa J,Irino Y, Tanaka S, Tsuda K, Takahashi S, et al. Metabolomics analysis of saliva from patients with primary Sjögren's syndrome. Clin Exp Immunol. [Internet]. 2015 Nov; 182(2): 149–153. [Cited 2021 Abr 15]. Available in: 10.1111/cei.12683SueroMetabolitoEcología autoinmuneAutoinmunidadMetabolómicaEsclerosis SistémicaSíndrome de SjögrenLICENSElicense.txtlicense.txttext/plain; charset=utf-814828https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5673/2/license.txt2f9959eaf5b71fae44bbf9ec84150c7aMD52open accessTEXTPerfil metabolómico diferencial en suero de pacientes con SSc y SSp.docx (1).pdf.txtPerfil metabolómico diferencial en suero de pacientes con SSc y SSp.docx (1).pdf.txtExtracted texttext/plain100501https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5673/6/Perfil%20metabol%c3%b3mico%20diferencial%20en%20suero%20de%20pacientes%20con%20SSc%20y%20SSp.docx%20%281%29.pdf.txt9507c027285d37edacb2395665180301MD56open accessPERFIL METABOLÓMICO DIFERENCIAL EN SUERO DE PACIENTES CON ESCLEROSIS SISTÉMICA Y SÍNDROME DE SJÖGREN..pdf.txtPERFIL METABOLÓMICO DIFERENCIAL EN SUERO DE PACIENTES CON ESCLEROSIS SISTÉMICA Y SÍNDROME DE SJÖGREN..pdf.txtExtracted texttext/plain6569https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5673/8/PERFIL%20METABOL%c3%93MICO%20DIFERENCIAL%20EN%20SUERO%20DE%20PACIENTES%20CON%20ESCLEROSIS%20SIST%c3%89MICA%20Y%20S%c3%8dNDROME%20DE%20SJ%c3%96GREN..pdf.txt23eb9a9e3b039d9571b7e40efdc99eaaMD58open accessFORMATO IDENTIFICACIÓN TRABAJOS DE GRADO(1) (2).pdf.txtFORMATO IDENTIFICACIÓN TRABAJOS DE GRADO(1) (2).pdf.txtExtracted texttext/plain2842https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5673/10/FORMATO%20IDENTIFICACI%c3%93N%20TRABAJOS%20DE%20GRADO%281%29%20%282%29.pdf.txte66171aa8e2e99a4d3a33072f08d1a84MD510metadata only accessCARTA DERECHOS DE AUTOR Moreno.pdf.txtCARTA DERECHOS DE AUTOR Moreno.pdf.txtExtracted texttext/plain1131https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5673/12/CARTA%20DERECHOS%20DE%20AUTOR%20Moreno.pdf.txt6d061587f2c279b6f94756191bc20cb5MD512metadata only accessTHUMBNAILPerfil metabolómico diferencial en suero de pacientes con SSc y SSp.docx (1).pdf.jpgPerfil metabolómico diferencial en suero de pacientes con SSc y SSp.docx (1).pdf.jpgGenerated Thumbnailimage/jpeg5716https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5673/7/Perfil%20metabol%c3%b3mico%20diferencial%20en%20suero%20de%20pacientes%20con%20SSc%20y%20SSp.docx%20%281%29.pdf.jpg0e25e77e8c24627387e3d03fa74de085MD57open accessPERFIL METABOLÓMICO DIFERENCIAL EN SUERO DE PACIENTES CON ESCLEROSIS SISTÉMICA Y SÍNDROME DE SJÖGREN..pdf.jpgPERFIL METABOLÓMICO DIFERENCIAL EN SUERO DE PACIENTES CON ESCLEROSIS SISTÉMICA Y SÍNDROME DE SJÖGREN..pdf.jpgGenerated Thumbnailimage/jpeg6257https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5673/9/PERFIL%20METABOL%c3%93MICO%20DIFERENCIAL%20EN%20SUERO%20DE%20PACIENTES%20CON%20ESCLEROSIS%20SIST%c3%89MICA%20Y%20S%c3%8dNDROME%20DE%20SJ%c3%96GREN..pdf.jpg049b90ce9d70e510632911381c7bd6a3MD59open accessFORMATO IDENTIFICACIÓN TRABAJOS DE GRADO(1) (2).pdf.jpgFORMATO IDENTIFICACIÓN TRABAJOS DE GRADO(1) (2).pdf.jpgGenerated Thumbnailimage/jpeg11236https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5673/11/FORMATO%20IDENTIFICACI%c3%93N%20TRABAJOS%20DE%20GRADO%281%29%20%282%29.pdf.jpg6476e48add1b4e6d9acf929809543079MD511metadata only accessCARTA DERECHOS DE AUTOR Moreno.pdf.jpgCARTA DERECHOS DE AUTOR Moreno.pdf.jpgGenerated Thumbnailimage/jpeg9343https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5673/13/CARTA%20DERECHOS%20DE%20AUTOR%20Moreno.pdf.jpg5cc543b4af894390b2b8b93ff520d27eMD513metadata only accessORIGINALPerfil metabolómico diferencial en suero de pacientes con SSc y SSp.docx (1).pdfPerfil metabolómico diferencial en suero de pacientes con SSc y SSp.docx (1).pdfapplication/pdf630506https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5673/14/Perfil%20metabol%c3%b3mico%20diferencial%20en%20suero%20de%20pacientes%20con%20SSc%20y%20SSp.docx%20%281%29.pdf10e5e8c13f80cb858e9d8fa98ac4a5b9MD514open accessPERFIL METABOLÓMICO DIFERENCIAL EN SUERO DE PACIENTES CON ESCLEROSIS SISTÉMICA Y SÍNDROME DE SJÖGREN..pdfPERFIL METABOLÓMICO DIFERENCIAL EN SUERO DE PACIENTES CON ESCLEROSIS SISTÉMICA Y SÍNDROME DE SJÖGREN..pdfapplication/pdf2543706https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5673/15/PERFIL%20METABOL%c3%93MICO%20DIFERENCIAL%20EN%20SUERO%20DE%20PACIENTES%20CON%20ESCLEROSIS%20SIST%c3%89MICA%20Y%20S%c3%8dNDROME%20DE%20SJ%c3%96GREN..pdf488182d58744cb369b3a4c44b2e90d57MD515open accessCARTA DERECHOS DE AUTOR Moreno.pdfCARTA DERECHOS DE AUTOR Moreno.pdfapplication/pdf154046https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5673/16/CARTA%20DERECHOS%20DE%20AUTOR%20Moreno.pdf193e8d468ee4fb04513ad9ac9a787806MD516metadata only accessFORMATO IDENTIFICACIÓN TRABAJOS DE GRADO(1) (2).pdfFORMATO IDENTIFICACIÓN TRABAJOS DE GRADO(1) (2).pdfapplication/pdf185825https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5673/17/FORMATO%20IDENTIFICACI%c3%93N%20TRABAJOS%20DE%20GRADO%281%29%20%282%29.pdfa414708b05a59fec2dea9018356e2535MD517metadata only accessunicolmayor/5673oai:repositorio.unicolmayor.edu.co:unicolmayor/56732024-05-09 14:17:22.9An error occurred on the license name.|||https://creativecommons.org/licenses/by-nc-sa/4.0/open accessBiblioteca Digital Unicolmayorrepositorio@unicolmayor.edu.coTEEgT0JSQSAoVEFMIFkgQ09NTyBTRSBERUZJTkUgTcOBUyBBREVMQU5URSkgU0UgT1RPUkdBIEJBSk8gTE9TIFRFUk1JTk9TIERFIEVTVEEgTElDRU5DSUEgUMOaQkxJQ0EgREUgQ1JFQVRJVkUgQ09NTU9OUyAo4oCcTFBDQ+KAnSBPIOKAnExJQ0VOQ0lB4oCdKS4gTEEgT0JSQSBFU1TDgSBQUk9URUdJREEgUE9SIERFUkVDSE9TIERFIEFVVE9SIFkvVSBPVFJBUyBMRVlFUyBBUExJQ0FCTEVTLiBRVUVEQSBQUk9ISUJJRE8gQ1VBTFFVSUVSIFVTTyBRVUUgU0UgSEFHQSBERSBMQSBPQlJBIFFVRSBOTyBDVUVOVEUgQ09OIExBIEFVVE9SSVpBQ0nDk04gUEVSVElORU5URSBERSBDT05GT1JNSURBRCBDT04gTE9TIFTDiVJNSU5PUyBERSBFU1RBIExJQ0VOQ0lBIFkgREUgTEEgTEVZIERFIERFUkVDSE8gREUgQVVUT1IuCgpNRURJQU5URSBFTCBFSkVSQ0lDSU8gREUgQ1VBTFFVSUVSQSBERSBMT1MgREVSRUNIT1MgUVVFIFNFIE9UT1JHQU4gRU4gRVNUQSBMSUNFTkNJQSwgVVNURUQgQUNFUFRBIFkgQUNVRVJEQSBRVUVEQVIgT0JMSUdBRE8gRU4gTE9TIFRFUk1JTk9TIFFVRSBTRSBTRcORQUxBTiBFTiBFTExBLiBFTCBMSUNFTkNJQU5URSBDT05DRURFIEEgVVNURUQgTE9TIERFUkVDSE9TIENPTlRFTklET1MgRU4gRVNUQSBMSUNFTkNJQSBDT05ESUNJT05BRE9TIEEgTEEgQUNFUFRBQ0nDk04gREUgU1VTIFRFUk1JTk9TIFkgQ09ORElDSU9ORVMuCjEuIERlZmluaWNpb25lcwoKYS4JT2JyYSBDb2xlY3RpdmEgZXMgdW5hIG9icmEsIHRhbCBjb21vIHVuYSBwdWJsaWNhY2nDs24gcGVyacOzZGljYSwgdW5hIGFudG9sb2fDrWEsIG8gdW5hIGVuY2ljbG9wZWRpYSwgZW4gbGEgcXVlIGxhIG9icmEgZW4gc3UgdG90YWxpZGFkLCBzaW4gbW9kaWZpY2FjacOzbiBhbGd1bmEsIGp1bnRvIGNvbiB1biBncnVwbyBkZSBvdHJhcyBjb250cmlidWNpb25lcyBxdWUgY29uc3RpdHV5ZW4gb2JyYXMgc2VwYXJhZGFzIGUgaW5kZXBlbmRpZW50ZXMgZW4gc8OtIG1pc21hcywgc2UgaW50ZWdyYW4gZW4gdW4gdG9kbyBjb2xlY3Rpdm8uIFVuYSBPYnJhIHF1ZSBjb25zdGl0dXllIHVuYSBvYnJhIGNvbGVjdGl2YSBubyBzZSBjb25zaWRlcmFyw6EgdW5hIE9icmEgRGVyaXZhZGEgKGNvbW8gc2UgZGVmaW5lIGFiYWpvKSBwYXJhIGxvcyBwcm9ww7NzaXRvcyBkZSBlc3RhIGxpY2VuY2lhLiBhcXVlbGxhIHByb2R1Y2lkYSBwb3IgdW4gZ3J1cG8gZGUgYXV0b3JlcywgZW4gcXVlIGxhIE9icmEgc2UgZW5jdWVudHJhIHNpbiBtb2RpZmljYWNpb25lcywganVudG8gY29uIHVuYSBjaWVydGEgY2FudGlkYWQgZGUgb3RyYXMgY29udHJpYnVjaW9uZXMsIHF1ZSBjb25zdGl0dXllbiBlbiBzw60gbWlzbW9zIHRyYWJham9zIHNlcGFyYWRvcyBlIGluZGVwZW5kaWVudGVzLCBxdWUgc29uIGludGVncmFkb3MgYWwgdG9kbyBjb2xlY3Rpdm8sIHRhbGVzIGNvbW8gcHVibGljYWNpb25lcyBwZXJpw7NkaWNhcywgYW50b2xvZ8OtYXMgbyBlbmNpY2xvcGVkaWFzLgoKYi4JT2JyYSBEZXJpdmFkYSBzaWduaWZpY2EgdW5hIG9icmEgYmFzYWRhIGVuIGxhIG9icmEgb2JqZXRvIGRlIGVzdGEgbGljZW5jaWEgbyBlbiDDqXN0YSB5IG90cmFzIG9icmFzIHByZWV4aXN0ZW50ZXMsIHRhbGVzIGNvbW8gdHJhZHVjY2lvbmVzLCBhcnJlZ2xvcyBtdXNpY2FsZXMsIGRyYW1hdGl6YWNpb25lcywg4oCcZmljY2lvbmFsaXphY2lvbmVz4oCdLCB2ZXJzaW9uZXMgcGFyYSBjaW5lLCDigJxncmFiYWNpb25lcyBkZSBzb25pZG/igJ0sIHJlcHJvZHVjY2lvbmVzIGRlIGFydGUsIHJlc8O6bWVuZXMsIGNvbmRlbnNhY2lvbmVzLCBvIGN1YWxxdWllciBvdHJhIGVuIGxhIHF1ZSBsYSBvYnJhIHB1ZWRhIHNlciB0cmFuc2Zvcm1hZGEsIGNhbWJpYWRhIG8gYWRhcHRhZGEsIGV4Y2VwdG8gYXF1ZWxsYXMgcXVlIGNvbnN0aXR1eWFuIHVuYSBvYnJhIGNvbGVjdGl2YSwgbGFzIHF1ZSBubyBzZXLDoW4gY29uc2lkZXJhZGFzIHVuYSBvYnJhIGRlcml2YWRhIHBhcmEgZWZlY3RvcyBkZSBlc3RhIGxpY2VuY2lhLiAoUGFyYSBldml0YXIgZHVkYXMsIGVuIGVsIGNhc28gZGUgcXVlIGxhIE9icmEgc2VhIHVuYSBjb21wb3NpY2nDs24gbXVzaWNhbCBvIHVuYSBncmFiYWNpw7NuIHNvbm9yYSwgcGFyYSBsb3MgZWZlY3RvcyBkZSBlc3RhIExpY2VuY2lhIGxhIHNpbmNyb25pemFjacOzbiB0ZW1wb3JhbCBkZSBsYSBPYnJhIGNvbiB1bmEgaW1hZ2VuIGVuIG1vdmltaWVudG8gc2UgY29uc2lkZXJhcsOhIHVuYSBPYnJhIERlcml2YWRhIHBhcmEgbG9zIGZpbmVzIGRlIGVzdGEgbGljZW5jaWEpLgoKYy4JTGljZW5jaWFudGUsIGVzIGVsIGluZGl2aWR1byBvIGxhIGVudGlkYWQgdGl0dWxhciBkZSBsb3MgZGVyZWNob3MgZGUgYXV0b3IgcXVlIG9mcmVjZSBsYSBPYnJhIGVuIGNvbmZvcm1pZGFkIGNvbiBsYXMgY29uZGljaW9uZXMgZGUgZXN0YSBMaWNlbmNpYS4KCmQuCUF1dG9yIG9yaWdpbmFsLCBlcyBlbCBpbmRpdmlkdW8gcXVlIGNyZcOzIGxhIE9icmEuCgplLglPYnJhLCBlcyBhcXVlbGxhIG9icmEgc3VzY2VwdGlibGUgZGUgcHJvdGVjY2nDs24gcG9yIGVsIHLDqWdpbWVuIGRlIERlcmVjaG8gZGUgQXV0b3IgeSBxdWUgZXMgb2ZyZWNpZGEgZW4gbG9zIHTDqXJtaW5vcyBkZSBlc3RhIGxpY2VuY2lhCgpmLglVc3RlZCwgZXMgZWwgaW5kaXZpZHVvIG8gbGEgZW50aWRhZCBxdWUgZWplcmNpdGEgbG9zIGRlcmVjaG9zIG90b3JnYWRvcyBhbCBhbXBhcm8gZGUgZXN0YSBMaWNlbmNpYSB5IHF1ZSBjb24gYW50ZXJpb3JpZGFkIG5vIGhhIHZpb2xhZG8gbGFzIGNvbmRpY2lvbmVzIGRlIGxhIG1pc21hIHJlc3BlY3RvIGEgbGEgT2JyYSwgbyBxdWUgaGF5YSBvYnRlbmlkbyBhdXRvcml6YWNpw7NuIGV4cHJlc2EgcG9yIHBhcnRlIGRlbCBMaWNlbmNpYW50ZSBwYXJhIGVqZXJjZXIgbG9zIGRlcmVjaG9zIGFsIGFtcGFybyBkZSBlc3RhIExpY2VuY2lhIHBlc2UgYSB1bmEgdmlvbGFjacOzbiBhbnRlcmlvci4KCjIuIERlcmVjaG9zIGRlIFVzb3MgSG9ucmFkb3MgeSBleGNlcGNpb25lcyBMZWdhbGVzLgpOYWRhIGVuIGVzdGEgTGljZW5jaWEgcG9kcsOhIHNlciBpbnRlcnByZXRhZG8gY29tbyB1bmEgZGlzbWludWNpw7NuLCBsaW1pdGFjacOzbiBvIHJlc3RyaWNjacOzbiBkZSBsb3MgZGVyZWNob3MgZGVyaXZhZG9zIGRlbCB1c28gaG9ucmFkbyB5IG90cmFzIGxpbWl0YWNpb25lcyBvIGV4Y2VwY2lvbmVzIGEgbG9zIGRlcmVjaG9zIGRlbCBhdXRvciBiYWpvIGVsIHLDqWdpbWVuIGxlZ2FsIHZpZ2VudGUgbyBkZXJpdmFkbyBkZSBjdWFscXVpZXIgb3RyYSBub3JtYSBxdWUgc2UgbGUgYXBsaXF1ZS4KCjMuIENvbmNlc2nDs24gZGUgbGEgTGljZW5jaWEuCkJham8gbG9zIHTDqXJtaW5vcyB5IGNvbmRpY2lvbmVzIGRlIGVzdGEgTGljZW5jaWEsIGVsIExpY2VuY2lhbnRlIG90b3JnYSBhIFVzdGVkIHVuYSBsaWNlbmNpYSBtdW5kaWFsLCBsaWJyZSBkZSByZWdhbMOtYXMsIG5vIGV4Y2x1c2l2YSB5IHBlcnBldHVhIChkdXJhbnRlIHRvZG8gZWwgcGVyw61vZG8gZGUgdmlnZW5jaWEgZGUgbG9zIGRlcmVjaG9zIGRlIGF1dG9yKSBwYXJhIGVqZXJjZXIgZXN0b3MgZGVyZWNob3Mgc29icmUgbGEgT2JyYSB0YWwgeSBjb21vIHNlIGluZGljYSBhIGNvbnRpbnVhY2nDs246CgphLglSZXByb2R1Y2lyIGxhIE9icmEsIGluY29ycG9yYXIgbGEgT2JyYSBlbiB1bmEgbyBtw6FzIE9icmFzIENvbGVjdGl2YXMsIHkgcmVwcm9kdWNpciBsYSBPYnJhIGluY29ycG9yYWRhIGVuIGxhcyBPYnJhcyBDb2xlY3RpdmFzLgoKYi4JRGlzdHJpYnVpciBjb3BpYXMgbyBmb25vZ3JhbWFzIGRlIGxhcyBPYnJhcywgZXhoaWJpcmxhcyBww7pibGljYW1lbnRlLCBlamVjdXRhcmxhcyBww7pibGljYW1lbnRlIHkvbyBwb25lcmxhcyBhIGRpc3Bvc2ljacOzbiBww7pibGljYSwgaW5jbHV5w6luZG9sYXMgY29tbyBpbmNvcnBvcmFkYXMgZW4gT2JyYXMgQ29sZWN0aXZhcywgc2Vnw7puIGNvcnJlc3BvbmRhLgoKYy4JRGlzdHJpYnVpciBjb3BpYXMgZGUgbGFzIE9icmFzIERlcml2YWRhcyBxdWUgc2UgZ2VuZXJlbiwgZXhoaWJpcmxhcyBww7pibGljYW1lbnRlLCBlamVjdXRhcmxhcyBww7pibGljYW1lbnRlIHkvbyBwb25lcmxhcyBhIGRpc3Bvc2ljacOzbiBww7pibGljYS4KTG9zIGRlcmVjaG9zIG1lbmNpb25hZG9zIGFudGVyaW9ybWVudGUgcHVlZGVuIHNlciBlamVyY2lkb3MgZW4gdG9kb3MgbG9zIG1lZGlvcyB5IGZvcm1hdG9zLCBhY3R1YWxtZW50ZSBjb25vY2lkb3MgbyBxdWUgc2UgaW52ZW50ZW4gZW4gZWwgZnV0dXJvLiBMb3MgZGVyZWNob3MgYW50ZXMgbWVuY2lvbmFkb3MgaW5jbHV5ZW4gZWwgZGVyZWNobyBhIHJlYWxpemFyIGRpY2hhcyBtb2RpZmljYWNpb25lcyBlbiBsYSBtZWRpZGEgcXVlIHNlYW4gdMOpY25pY2FtZW50ZSBuZWNlc2FyaWFzIHBhcmEgZWplcmNlciBsb3MgZGVyZWNob3MgZW4gb3RybyBtZWRpbyBvIGZvcm1hdG9zLCBwZXJvIGRlIG90cmEgbWFuZXJhIHVzdGVkIG5vIGVzdMOhIGF1dG9yaXphZG8gcGFyYSByZWFsaXphciBvYnJhcyBkZXJpdmFkYXMuIFRvZG9zIGxvcyBkZXJlY2hvcyBubyBvdG9yZ2Fkb3MgZXhwcmVzYW1lbnRlIHBvciBlbCBMaWNlbmNpYW50ZSBxdWVkYW4gcG9yIGVzdGUgbWVkaW8gcmVzZXJ2YWRvcywgaW5jbHV5ZW5kbyBwZXJvIHNpbiBsaW1pdGFyc2UgYSBhcXVlbGxvcyBxdWUgc2UgbWVuY2lvbmFuIGVuIGxhcyBzZWNjaW9uZXMgNChkKSB5IDQoZSkuCgo0LiBSZXN0cmljY2lvbmVzLgpMYSBsaWNlbmNpYSBvdG9yZ2FkYSBlbiBsYSBhbnRlcmlvciBTZWNjacOzbiAzIGVzdMOhIGV4cHJlc2FtZW50ZSBzdWpldGEgeSBsaW1pdGFkYSBwb3IgbGFzIHNpZ3VpZW50ZXMgcmVzdHJpY2Npb25lczoKCmEuCVVzdGVkIHB1ZWRlIGRpc3RyaWJ1aXIsIGV4aGliaXIgcMO6YmxpY2FtZW50ZSwgZWplY3V0YXIgcMO6YmxpY2FtZW50ZSwgbyBwb25lciBhIGRpc3Bvc2ljacOzbiBww7pibGljYSBsYSBPYnJhIHPDs2xvIGJham8gbGFzIGNvbmRpY2lvbmVzIGRlIGVzdGEgTGljZW5jaWEsIHkgVXN0ZWQgZGViZSBpbmNsdWlyIHVuYSBjb3BpYSBkZSBlc3RhIGxpY2VuY2lhIG8gZGVsIElkZW50aWZpY2Fkb3IgVW5pdmVyc2FsIGRlIFJlY3Vyc29zIGRlIGxhIG1pc21hIGNvbiBjYWRhIGNvcGlhIGRlIGxhIE9icmEgcXVlIGRpc3RyaWJ1eWEsIGV4aGliYSBww7pibGljYW1lbnRlLCBlamVjdXRlIHDDumJsaWNhbWVudGUgbyBwb25nYSBhIGRpc3Bvc2ljacOzbiBww7pibGljYS4gTm8gZXMgcG9zaWJsZSBvZnJlY2VyIG8gaW1wb25lciBuaW5ndW5hIGNvbmRpY2nDs24gc29icmUgbGEgT2JyYSBxdWUgYWx0ZXJlIG8gbGltaXRlIGxhcyBjb25kaWNpb25lcyBkZSBlc3RhIExpY2VuY2lhIG8gZWwgZWplcmNpY2lvIGRlIGxvcyBkZXJlY2hvcyBkZSBsb3MgZGVzdGluYXRhcmlvcyBvdG9yZ2Fkb3MgZW4gZXN0ZSBkb2N1bWVudG8uIE5vIGVzIHBvc2libGUgc3VibGljZW5jaWFyIGxhIE9icmEuIFVzdGVkIGRlYmUgbWFudGVuZXIgaW50YWN0b3MgdG9kb3MgbG9zIGF2aXNvcyBxdWUgaGFnYW4gcmVmZXJlbmNpYSBhIGVzdGEgTGljZW5jaWEgeSBhIGxhIGNsw6F1c3VsYSBkZSBsaW1pdGFjacOzbiBkZSBnYXJhbnTDrWFzLiBVc3RlZCBubyBwdWVkZSBkaXN0cmlidWlyLCBleGhpYmlyIHDDumJsaWNhbWVudGUsIGVqZWN1dGFyIHDDumJsaWNhbWVudGUsIG8gcG9uZXIgYSBkaXNwb3NpY2nDs24gcMO6YmxpY2EgbGEgT2JyYSBjb24gYWxndW5hIG1lZGlkYSB0ZWNub2zDs2dpY2EgcXVlIGNvbnRyb2xlIGVsIGFjY2VzbyBvIGxhIHV0aWxpemFjacOzbiBkZSBlbGxhIGRlIHVuYSBmb3JtYSBxdWUgc2VhIGluY29uc2lzdGVudGUgY29uIGxhcyBjb25kaWNpb25lcyBkZSBlc3RhIExpY2VuY2lhLiBMbyBhbnRlcmlvciBzZSBhcGxpY2EgYSBsYSBPYnJhIGluY29ycG9yYWRhIGEgdW5hIE9icmEgQ29sZWN0aXZhLCBwZXJvIGVzdG8gbm8gZXhpZ2UgcXVlIGxhIE9icmEgQ29sZWN0aXZhIGFwYXJ0ZSBkZSBsYSBvYnJhIG1pc21hIHF1ZWRlIHN1amV0YSBhIGxhcyBjb25kaWNpb25lcyBkZSBlc3RhIExpY2VuY2lhLiBTaSBVc3RlZCBjcmVhIHVuYSBPYnJhIENvbGVjdGl2YSwgcHJldmlvIGF2aXNvIGRlIGN1YWxxdWllciBMaWNlbmNpYW50ZSBkZWJlLCBlbiBsYSBtZWRpZGEgZGUgbG8gcG9zaWJsZSwgZWxpbWluYXIgZGUgbGEgT2JyYSBDb2xlY3RpdmEgY3VhbHF1aWVyIHJlZmVyZW5jaWEgYSBkaWNobyBMaWNlbmNpYW50ZSBvIGFsIEF1dG9yIE9yaWdpbmFsLCBzZWfDum4gbG8gc29saWNpdGFkbyBwb3IgZWwgTGljZW5jaWFudGUgeSBjb25mb3JtZSBsbyBleGlnZSBsYSBjbMOhdXN1bGEgNChjKS4KCmIuCVVzdGVkIG5vIHB1ZWRlIGVqZXJjZXIgbmluZ3VubyBkZSBsb3MgZGVyZWNob3MgcXVlIGxlIGhhbiBzaWRvIG90b3JnYWRvcyBlbiBsYSBTZWNjacOzbiAzIHByZWNlZGVudGUgZGUgbW9kbyBxdWUgZXN0w6luIHByaW5jaXBhbG1lbnRlIGRlc3RpbmFkb3MgbyBkaXJlY3RhbWVudGUgZGlyaWdpZG9zIGEgY29uc2VndWlyIHVuIHByb3ZlY2hvIGNvbWVyY2lhbCBvIHVuYSBjb21wZW5zYWNpw7NuIG1vbmV0YXJpYSBwcml2YWRhLiBFbCBpbnRlcmNhbWJpbyBkZSBsYSBPYnJhIHBvciBvdHJhcyBvYnJhcyBwcm90ZWdpZGFzIHBvciBkZXJlY2hvcyBkZSBhdXRvciwgeWEgc2VhIGEgdHJhdsOpcyBkZSB1biBzaXN0ZW1hIHBhcmEgY29tcGFydGlyIGFyY2hpdm9zIGRpZ2l0YWxlcyAoZGlnaXRhbCBmaWxlLXNoYXJpbmcpIG8gZGUgY3VhbHF1aWVyIG90cmEgbWFuZXJhIG5vIHNlcsOhIGNvbnNpZGVyYWRvIGNvbW8gZXN0YXIgZGVzdGluYWRvIHByaW5jaXBhbG1lbnRlIG8gZGlyaWdpZG8gZGlyZWN0YW1lbnRlIGEgY29uc2VndWlyIHVuIHByb3ZlY2hvIGNvbWVyY2lhbCBvIHVuYSBjb21wZW5zYWNpw7NuIG1vbmV0YXJpYSBwcml2YWRhLCBzaWVtcHJlIHF1ZSBubyBzZSByZWFsaWNlIHVuIHBhZ28gbWVkaWFudGUgdW5hIGNvbXBlbnNhY2nDs24gbW9uZXRhcmlhIGVuIHJlbGFjacOzbiBjb24gZWwgaW50ZXJjYW1iaW8gZGUgb2JyYXMgcHJvdGVnaWRhcyBwb3IgZWwgZGVyZWNobyBkZSBhdXRvci4KCmMuCVNpIHVzdGVkIGRpc3RyaWJ1eWUsIGV4aGliZSBww7pibGljYW1lbnRlLCBlamVjdXRhIHDDumJsaWNhbWVudGUgbyBlamVjdXRhIHDDumJsaWNhbWVudGUgZW4gZm9ybWEgZGlnaXRhbCBsYSBPYnJhIG8gY3VhbHF1aWVyIE9icmEgRGVyaXZhZGEgdSBPYnJhIENvbGVjdGl2YSwgVXN0ZWQgZGViZSBtYW50ZW5lciBpbnRhY3RhIHRvZGEgbGEgaW5mb3JtYWNpw7NuIGRlIGRlcmVjaG8gZGUgYXV0b3IgZGUgbGEgT2JyYSB5IHByb3BvcmNpb25hciwgZGUgZm9ybWEgcmF6b25hYmxlIHNlZ8O6biBlbCBtZWRpbyBvIG1hbmVyYSBxdWUgVXN0ZWQgZXN0w6kgdXRpbGl6YW5kbzogKGkpIGVsIG5vbWJyZSBkZWwgQXV0b3IgT3JpZ2luYWwgc2kgZXN0w6EgcHJvdmlzdG8gKG8gc2V1ZMOzbmltbywgc2kgZnVlcmUgYXBsaWNhYmxlKSwgeS9vIChpaSkgZWwgbm9tYnJlIGRlIGxhIHBhcnRlIG8gbGFzIHBhcnRlcyBxdWUgZWwgQXV0b3IgT3JpZ2luYWwgeS9vIGVsIExpY2VuY2lhbnRlIGh1YmllcmVuIGRlc2lnbmFkbyBwYXJhIGxhIGF0cmlidWNpw7NuICh2LmcuLCB1biBpbnN0aXR1dG8gcGF0cm9jaW5hZG9yLCBlZGl0b3JpYWwsIHB1YmxpY2FjacOzbikgZW4gbGEgaW5mb3JtYWNpw7NuIGRlIGxvcyBkZXJlY2hvcyBkZSBhdXRvciBkZWwgTGljZW5jaWFudGUsIHTDqXJtaW5vcyBkZSBzZXJ2aWNpb3MgbyBkZSBvdHJhcyBmb3JtYXMgcmF6b25hYmxlczsgZWwgdMOtdHVsbyBkZSBsYSBPYnJhIHNpIGVzdMOhIHByb3Zpc3RvOyBlbiBsYSBtZWRpZGEgZGUgbG8gcmF6b25hYmxlbWVudGUgZmFjdGlibGUgeSwgc2kgZXN0w6EgcHJvdmlzdG8sIGVsIElkZW50aWZpY2Fkb3IgVW5pZm9ybWUgZGUgUmVjdXJzb3MgKFVuaWZvcm0gUmVzb3VyY2UgSWRlbnRpZmllcikgcXVlIGVsIExpY2VuY2lhbnRlIGVzcGVjaWZpY2EgcGFyYSBzZXIgYXNvY2lhZG8gY29uIGxhIE9icmEsIHNhbHZvIHF1ZSB0YWwgVVJJIG5vIHNlIHJlZmllcmEgYSBsYSBub3RhIHNvYnJlIGxvcyBkZXJlY2hvcyBkZSBhdXRvciBvIGEgbGEgaW5mb3JtYWNpw7NuIHNvYnJlIGVsIGxpY2VuY2lhbWllbnRvIGRlIGxhIE9icmE7IHkgZW4gZWwgY2FzbyBkZSB1bmEgT2JyYSBEZXJpdmFkYSwgYXRyaWJ1aXIgZWwgY3LDqWRpdG8gaWRlbnRpZmljYW5kbyBlbCB1c28gZGUgbGEgT2JyYSBlbiBsYSBPYnJhIERlcml2YWRhICh2LmcuLCAiVHJhZHVjY2nDs24gRnJhbmNlc2EgZGUgbGEgT2JyYSBkZWwgQXV0b3IgT3JpZ2luYWwsIiBvICJHdWnDs24gQ2luZW1hdG9ncsOhZmljbyBiYXNhZG8gZW4gbGEgT2JyYSBvcmlnaW5hbCBkZWwgQXV0b3IgT3JpZ2luYWwiKS4gVGFsIGNyw6lkaXRvIHB1ZWRlIHNlciBpbXBsZW1lbnRhZG8gZGUgY3VhbHF1aWVyIGZvcm1hIHJhem9uYWJsZTsgZW4gZWwgY2Fzbywgc2luIGVtYmFyZ28sIGRlIE9icmFzIERlcml2YWRhcyB1IE9icmFzIENvbGVjdGl2YXMsIHRhbCBjcsOpZGl0byBhcGFyZWNlcsOhLCBjb21vIG3DrW5pbW8sIGRvbmRlIGFwYXJlY2UgZWwgY3LDqWRpdG8gZGUgY3VhbHF1aWVyIG90cm8gYXV0b3IgY29tcGFyYWJsZSB5IGRlIHVuYSBtYW5lcmEsIGFsIG1lbm9zLCB0YW4gZGVzdGFjYWRhIGNvbW8gZWwgY3LDqWRpdG8gZGUgb3RybyBhdXRvciBjb21wYXJhYmxlLgoKZC4JUGFyYSBldml0YXIgdG9kYSBjb25mdXNpw7NuLCBlbCBMaWNlbmNpYW50ZSBhY2xhcmEgcXVlLCBjdWFuZG8gbGEgb2JyYSBlcyB1bmEgY29tcG9zaWNpw7NuIG11c2ljYWw6CgppLglSZWdhbMOtYXMgcG9yIGludGVycHJldGFjacOzbiB5IGVqZWN1Y2nDs24gYmFqbyBsaWNlbmNpYXMgZ2VuZXJhbGVzLiBFbCBMaWNlbmNpYW50ZSBzZSByZXNlcnZhIGVsIGRlcmVjaG8gZXhjbHVzaXZvIGRlIGF1dG9yaXphciBsYSBlamVjdWNpw7NuIHDDumJsaWNhIG8gbGEgZWplY3VjacOzbiBww7pibGljYSBkaWdpdGFsIGRlIGxhIG9icmEgeSBkZSByZWNvbGVjdGFyLCBzZWEgaW5kaXZpZHVhbG1lbnRlIG8gYSB0cmF2w6lzIGRlIHVuYSBzb2NpZWRhZCBkZSBnZXN0acOzbiBjb2xlY3RpdmEgZGUgZGVyZWNob3MgZGUgYXV0b3IgeSBkZXJlY2hvcyBjb25leG9zIChwb3IgZWplbXBsbywgU0FZQ08pLCBsYXMgcmVnYWzDrWFzIHBvciBsYSBlamVjdWNpw7NuIHDDumJsaWNhIG8gcG9yIGxhIGVqZWN1Y2nDs24gcMO6YmxpY2EgZGlnaXRhbCBkZSBsYSBvYnJhIChwb3IgZWplbXBsbyBXZWJjYXN0KSBsaWNlbmNpYWRhIGJham8gbGljZW5jaWFzIGdlbmVyYWxlcywgc2kgbGEgaW50ZXJwcmV0YWNpw7NuIG8gZWplY3VjacOzbiBkZSBsYSBvYnJhIGVzdMOhIHByaW1vcmRpYWxtZW50ZSBvcmllbnRhZGEgcG9yIG8gZGlyaWdpZGEgYSBsYSBvYnRlbmNpw7NuIGRlIHVuYSB2ZW50YWphIGNvbWVyY2lhbCBvIHVuYSBjb21wZW5zYWNpw7NuIG1vbmV0YXJpYSBwcml2YWRhLgoKaWkuCVJlZ2Fsw61hcyBwb3IgRm9ub2dyYW1hcy4gRWwgTGljZW5jaWFudGUgc2UgcmVzZXJ2YSBlbCBkZXJlY2hvIGV4Y2x1c2l2byBkZSByZWNvbGVjdGFyLCBpbmRpdmlkdWFsbWVudGUgbyBhIHRyYXbDqXMgZGUgdW5hIHNvY2llZGFkIGRlIGdlc3Rpw7NuIGNvbGVjdGl2YSBkZSBkZXJlY2hvcyBkZSBhdXRvciB5IGRlcmVjaG9zIGNvbmV4b3MgKHBvciBlamVtcGxvLCBsb3MgY29uc2FncmFkb3MgcG9yIGxhIFNBWUNPKSwgdW5hIGFnZW5jaWEgZGUgZGVyZWNob3MgbXVzaWNhbGVzIG8gYWxnw7puIGFnZW50ZSBkZXNpZ25hZG8sIGxhcyByZWdhbMOtYXMgcG9yIGN1YWxxdWllciBmb25vZ3JhbWEgcXVlIFVzdGVkIGNyZWUgYSBwYXJ0aXIgZGUgbGEgb2JyYSAo4oCcdmVyc2nDs24gY292ZXLigJ0pIHkgZGlzdHJpYnV5YSwgZW4gbG9zIHTDqXJtaW5vcyBkZWwgcsOpZ2ltZW4gZGUgZGVyZWNob3MgZGUgYXV0b3IsIHNpIGxhIGNyZWFjacOzbiBvIGRpc3RyaWJ1Y2nDs24gZGUgZXNhIHZlcnNpw7NuIGNvdmVyIGVzdMOhIHByaW1vcmRpYWxtZW50ZSBkZXN0aW5hZGEgbyBkaXJpZ2lkYSBhIG9idGVuZXIgdW5hIHZlbnRhamEgY29tZXJjaWFsIG8gdW5hIGNvbXBlbnNhY2nDs24gbW9uZXRhcmlhIHByaXZhZGEuCgplLglHZXN0acOzbiBkZSBEZXJlY2hvcyBkZSBBdXRvciBzb2JyZSBJbnRlcnByZXRhY2lvbmVzIHkgRWplY3VjaW9uZXMgRGlnaXRhbGVzIChXZWJDYXN0aW5nKS4gUGFyYSBldml0YXIgdG9kYSBjb25mdXNpw7NuLCBlbCBMaWNlbmNpYW50ZSBhY2xhcmEgcXVlLCBjdWFuZG8gbGEgb2JyYSBzZWEgdW4gZm9ub2dyYW1hLCBlbCBMaWNlbmNpYW50ZSBzZSByZXNlcnZhIGVsIGRlcmVjaG8gZXhjbHVzaXZvIGRlIGF1dG9yaXphciBsYSBlamVjdWNpw7NuIHDDumJsaWNhIGRpZ2l0YWwgZGUgbGEgb2JyYSAocG9yIGVqZW1wbG8sIHdlYmNhc3QpIHkgZGUgcmVjb2xlY3RhciwgaW5kaXZpZHVhbG1lbnRlIG8gYSB0cmF2w6lzIGRlIHVuYSBzb2NpZWRhZCBkZSBnZXN0acOzbiBjb2xlY3RpdmEgZGUgZGVyZWNob3MgZGUgYXV0b3IgeSBkZXJlY2hvcyBjb25leG9zIChwb3IgZWplbXBsbywgQUNJTlBSTyksIGxhcyByZWdhbMOtYXMgcG9yIGxhIGVqZWN1Y2nDs24gcMO6YmxpY2EgZGlnaXRhbCBkZSBsYSBvYnJhIChwb3IgZWplbXBsbywgd2ViY2FzdCksIHN1amV0YSBhIGxhcyBkaXNwb3NpY2lvbmVzIGFwbGljYWJsZXMgZGVsIHLDqWdpbWVuIGRlIERlcmVjaG8gZGUgQXV0b3IsIHNpIGVzdGEgZWplY3VjacOzbiBww7pibGljYSBkaWdpdGFsIGVzdMOhIHByaW1vcmRpYWxtZW50ZSBkaXJpZ2lkYSBhIG9idGVuZXIgdW5hIHZlbnRhamEgY29tZXJjaWFsIG8gdW5hIGNvbXBlbnNhY2nDs24gbW9uZXRhcmlhIHByaXZhZGEuCgo1LiBSZXByZXNlbnRhY2lvbmVzLCBHYXJhbnTDrWFzIHkgTGltaXRhY2lvbmVzIGRlIFJlc3BvbnNhYmlsaWRhZC4KQSBNRU5PUyBRVUUgTEFTIFBBUlRFUyBMTyBBQ09SREFSQU4gREUgT1RSQSBGT1JNQSBQT1IgRVNDUklUTywgRUwgTElDRU5DSUFOVEUgT0ZSRUNFIExBIE9CUkEgKEVOIEVMIEVTVEFETyBFTiBFTCBRVUUgU0UgRU5DVUVOVFJBKSDigJxUQUwgQ1VBTOKAnSwgU0lOIEJSSU5EQVIgR0FSQU5Uw41BUyBERSBDTEFTRSBBTEdVTkEgUkVTUEVDVE8gREUgTEEgT0JSQSwgWUEgU0VBIEVYUFJFU0EsIElNUEzDjUNJVEEsIExFR0FMIE8gQ1VBTFFVSUVSQSBPVFJBLCBJTkNMVVlFTkRPLCBTSU4gTElNSVRBUlNFIEEgRUxMQVMsIEdBUkFOVMONQVMgREUgVElUVUxBUklEQUQsIENPTUVSQ0lBQklMSURBRCwgQURBUFRBQklMSURBRCBPIEFERUNVQUNJw5NOIEEgUFJPUMOTU0lUTyBERVRFUk1JTkFETywgQVVTRU5DSUEgREUgSU5GUkFDQ0nDk04sIERFIEFVU0VOQ0lBIERFIERFRkVDVE9TIExBVEVOVEVTIE8gREUgT1RSTyBUSVBPLCBPIExBIFBSRVNFTkNJQSBPIEFVU0VOQ0lBIERFIEVSUk9SRVMsIFNFQU4gTyBOTyBERVNDVUJSSUJMRVMgKFBVRURBTiBPIE5PIFNFUiBFU1RPUyBERVNDVUJJRVJUT1MpLiBBTEdVTkFTIEpVUklTRElDQ0lPTkVTIE5PIFBFUk1JVEVOIExBIEVYQ0xVU0nDk04gREUgR0FSQU5Uw41BUyBJTVBMw41DSVRBUywgRU4gQ1VZTyBDQVNPIEVTVEEgRVhDTFVTScOTTiBQVUVERSBOTyBBUExJQ0FSU0UgQSBVU1RFRC4KCjYuIExpbWl0YWNpw7NuIGRlIHJlc3BvbnNhYmlsaWRhZC4KQSBNRU5PUyBRVUUgTE8gRVhJSkEgRVhQUkVTQU1FTlRFIExBIExFWSBBUExJQ0FCTEUsIEVMIExJQ0VOQ0lBTlRFIE5PIFNFUsOBIFJFU1BPTlNBQkxFIEFOVEUgVVNURUQgUE9SIERBw5FPIEFMR1VOTywgU0VBIFBPUiBSRVNQT05TQUJJTElEQUQgRVhUUkFDT05UUkFDVFVBTCwgUFJFQ09OVFJBQ1RVQUwgTyBDT05UUkFDVFVBTCwgT0JKRVRJVkEgTyBTVUJKRVRJVkEsIFNFIFRSQVRFIERFIERBw5FPUyBNT1JBTEVTIE8gUEFUUklNT05JQUxFUywgRElSRUNUT1MgTyBJTkRJUkVDVE9TLCBQUkVWSVNUT1MgTyBJTVBSRVZJU1RPUyBQUk9EVUNJRE9TIFBPUiBFTCBVU08gREUgRVNUQSBMSUNFTkNJQSBPIERFIExBIE9CUkEsIEFVTiBDVUFORE8gRUwgTElDRU5DSUFOVEUgSEFZQSBTSURPIEFEVkVSVElETyBERSBMQSBQT1NJQklMSURBRCBERSBESUNIT1MgREHDkU9TLiBBTEdVTkFTIExFWUVTIE5PIFBFUk1JVEVOIExBIEVYQ0xVU0nDk04gREUgQ0lFUlRBIFJFU1BPTlNBQklMSURBRCwgRU4gQ1VZTyBDQVNPIEVTVEEgRVhDTFVTScOTTiBQVUVERSBOTyBBUExJQ0FSU0UgQSBVU1RFRC4KCjcuIFTDqXJtaW5vLgoKYS4JRXN0YSBMaWNlbmNpYSB5IGxvcyBkZXJlY2hvcyBvdG9yZ2Fkb3MgZW4gdmlydHVkIGRlIGVsbGEgdGVybWluYXLDoW4gYXV0b23DoXRpY2FtZW50ZSBzaSBVc3RlZCBpbmZyaW5nZSBhbGd1bmEgY29uZGljacOzbiBlc3RhYmxlY2lkYSBlbiBlbGxhLiBTaW4gZW1iYXJnbywgbG9zIGluZGl2aWR1b3MgbyBlbnRpZGFkZXMgcXVlIGhhbiByZWNpYmlkbyBPYnJhcyBEZXJpdmFkYXMgbyBDb2xlY3RpdmFzIGRlIFVzdGVkIGRlIGNvbmZvcm1pZGFkIGNvbiBlc3RhIExpY2VuY2lhLCBubyB2ZXLDoW4gdGVybWluYWRhcyBzdXMgbGljZW5jaWFzLCBzaWVtcHJlIHF1ZSBlc3RvcyBpbmRpdmlkdW9zIG8gZW50aWRhZGVzIHNpZ2FuIGN1bXBsaWVuZG8gw61udGVncmFtZW50ZSBsYXMgY29uZGljaW9uZXMgZGUgZXN0YXMgbGljZW5jaWFzLiBMYXMgU2VjY2lvbmVzIDEsIDIsIDUsIDYsIDcsIHkgOCBzdWJzaXN0aXLDoW4gYSBjdWFscXVpZXIgdGVybWluYWNpw7NuIGRlIGVzdGEgTGljZW5jaWEuCgpiLglTdWpldGEgYSBsYXMgY29uZGljaW9uZXMgeSB0w6lybWlub3MgYW50ZXJpb3JlcywgbGEgbGljZW5jaWEgb3RvcmdhZGEgYXF1w60gZXMgcGVycGV0dWEgKGR1cmFudGUgZWwgcGVyw61vZG8gZGUgdmlnZW5jaWEgZGUgbG9zIGRlcmVjaG9zIGRlIGF1dG9yIGRlIGxhIG9icmEpLiBObyBvYnN0YW50ZSBsbyBhbnRlcmlvciwgZWwgTGljZW5jaWFudGUgc2UgcmVzZXJ2YSBlbCBkZXJlY2hvIGEgcHVibGljYXIgeS9vIGVzdHJlbmFyIGxhIE9icmEgYmFqbyBjb25kaWNpb25lcyBkZSBsaWNlbmNpYSBkaWZlcmVudGVzIG8gYSBkZWphciBkZSBkaXN0cmlidWlybGEgZW4gbG9zIHTDqXJtaW5vcyBkZSBlc3RhIExpY2VuY2lhIGVuIGN1YWxxdWllciBtb21lbnRvOyBlbiBlbCBlbnRlbmRpZG8sIHNpbiBlbWJhcmdvLCBxdWUgZXNhIGVsZWNjacOzbiBubyBzZXJ2aXLDoSBwYXJhIHJldm9jYXIgZXN0YSBsaWNlbmNpYSBvIHF1ZSBkZWJhIHNlciBvdG9yZ2FkYSAsIGJham8gbG9zIHTDqXJtaW5vcyBkZSBlc3RhIGxpY2VuY2lhKSwgeSBlc3RhIGxpY2VuY2lhIGNvbnRpbnVhcsOhIGVuIHBsZW5vIHZpZ29yIHkgZWZlY3RvIGEgbWVub3MgcXVlIHNlYSB0ZXJtaW5hZGEgY29tbyBzZSBleHByZXNhIGF0csOhcy4gTGEgTGljZW5jaWEgcmV2b2NhZGEgY29udGludWFyw6Egc2llbmRvIHBsZW5hbWVudGUgdmlnZW50ZSB5IGVmZWN0aXZhIHNpIG5vIHNlIGxlIGRhIHTDqXJtaW5vIGVuIGxhcyBjb25kaWNpb25lcyBpbmRpY2FkYXMgYW50ZXJpb3JtZW50ZS4KCjguIFZhcmlvcy4KCmEuCUNhZGEgdmV6IHF1ZSBVc3RlZCBkaXN0cmlidXlhIG8gcG9uZ2EgYSBkaXNwb3NpY2nDs24gcMO6YmxpY2EgbGEgT2JyYSBvIHVuYSBPYnJhIENvbGVjdGl2YSwgZWwgTGljZW5jaWFudGUgb2ZyZWNlcsOhIGFsIGRlc3RpbmF0YXJpbyB1bmEgbGljZW5jaWEgZW4gbG9zIG1pc21vcyB0w6lybWlub3MgeSBjb25kaWNpb25lcyBxdWUgbGEgbGljZW5jaWEgb3RvcmdhZGEgYSBVc3RlZCBiYWpvIGVzdGEgTGljZW5jaWEuCgpiLglTaSBhbGd1bmEgZGlzcG9zaWNpw7NuIGRlIGVzdGEgTGljZW5jaWEgcmVzdWx0YSBpbnZhbGlkYWRhIG8gbm8gZXhpZ2libGUsIHNlZ8O6biBsYSBsZWdpc2xhY2nDs24gdmlnZW50ZSwgZXN0byBubyBhZmVjdGFyw6EgbmkgbGEgdmFsaWRleiBuaSBsYSBhcGxpY2FiaWxpZGFkIGRlbCByZXN0byBkZSBjb25kaWNpb25lcyBkZSBlc3RhIExpY2VuY2lhIHksIHNpbiBhY2Npw7NuIGFkaWNpb25hbCBwb3IgcGFydGUgZGUgbG9zIHN1amV0b3MgZGUgZXN0ZSBhY3VlcmRvLCBhcXXDqWxsYSBzZSBlbnRlbmRlcsOhIHJlZm9ybWFkYSBsbyBtw61uaW1vIG5lY2VzYXJpbyBwYXJhIGhhY2VyIHF1ZSBkaWNoYSBkaXNwb3NpY2nDs24gc2VhIHbDoWxpZGEgeSBleGlnaWJsZS4KCmMuCU5pbmfDum4gdMOpcm1pbm8gbyBkaXNwb3NpY2nDs24gZGUgZXN0YSBMaWNlbmNpYSBzZSBlc3RpbWFyw6EgcmVudW5jaWFkYSB5IG5pbmd1bmEgdmlvbGFjacOzbiBkZSBlbGxhIHNlcsOhIGNvbnNlbnRpZGEgYSBtZW5vcyBxdWUgZXNhIHJlbnVuY2lhIG8gY29uc2VudGltaWVudG8gc2VhIG90b3JnYWRvIHBvciBlc2NyaXRvIHkgZmlybWFkbyBwb3IgbGEgcGFydGUgcXVlIHJlbnVuY2llIG8gY29uc2llbnRhLgoKZC4JRXN0YSBMaWNlbmNpYSByZWZsZWphIGVsIGFjdWVyZG8gcGxlbm8gZW50cmUgbGFzIHBhcnRlcyByZXNwZWN0byBhIGxhIE9icmEgYXF1w60gbGljZW5jaWFkYS4gTm8gaGF5IGFycmVnbG9zLCBhY3VlcmRvcyBvIGRlY2xhcmFjaW9uZXMgcmVzcGVjdG8gYSBsYSBPYnJhIHF1ZSBubyBlc3TDqW4gZXNwZWNpZmljYWRvcyBlbiBlc3RlIGRvY3VtZW50by4gRWwgTGljZW5jaWFudGUgbm8gc2UgdmVyw6EgbGltaXRhZG8gcG9yIG5pbmd1bmEgZGlzcG9zaWNpw7NuIGFkaWNpb25hbCBxdWUgcHVlZGEgc3VyZ2lyIGVuIGFsZ3VuYSBjb211bmljYWNpw7NuIGVtYW5hZGEgZGUgVXN0ZWQuIEVzdGEgTGljZW5jaWEgbm8gcHVlZGUgc2VyIG1vZGlmaWNhZGEgc2luIGVsIGNvbnNlbnRpbWllbnRvIG11dHVvIHBvciBlc2NyaXRvIGRlbCBMaWNlbmNpYW50ZSB5IFVzdGVkLgo=

Publicaciones similares